Additionally, the exenatide treated group exhibited lower dopamine transporter availability relative to placebo, and exploratory analyses indicated that exenatide significantly reduced both heavy drinking days and total alcohol intake among obese patients (Klausen et al., 2022)
The present study aimed to evaluate potential alterations and dynamics of circulating GLP-1 and GLP-2 in patients undergoing liver resections, focusing on post-hepatectomy liver failure (PHLF)
The 25-mg dose resulted in substantial weight loss with a safety profile consistent with that of the GLP-1 class of medications, wrote the research team led by Dr
It did not test this subcutaneous schedule
Which Fruit Has More Vitamin C
McEvoy RD, Antic NA, Heeley E, et al